The Knockdown of ETV4 Inhibits the Papillary Thyroid Cancer Development by Promoting Ferroptosis Upon SLC7A11 Downregulation

KIF2A promotes the progression via AKT signaling pathway and is upregulated by transcription factor ETV4 in human gastric cancer

(2020) Xin Zhang et al.   BIOMEDICINE & PHARMACOTHERAPY

ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21

(2020) Irene Cosi et al.   Journal of Hematology & Oncology

Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy

(2020) Pranavi Koppula et al.   Protein & Cell

CRLF1–MYH9 Interaction Regulates Proliferation and Metastasis of Papillary Thyroid Carcinoma Through the ERK/ETV4 Axis

(2020) Shi-Tong Yu et al.   Frontiers in Endocrinology

Ferroptosis, a new form of cell death: opportunities and challenges in cancer

(2019) Yanhua Mou et al.   Journal of Hematology & Oncology

The deubiquitylase OTUB1 mediates ferroptosis via stabilization of SLC7A11

(2019) Tong Liu et al.   CANCER RESEARCH

Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer

(2019) Young Shin Song et al.   ENDOCRINE-RELATED CANCER

Critical role of the MCAM-ETV4 axis triggered by extracellular S100A8/A9 in breast cancer aggressiveness

(2019) Youyi Chen et al.   NEOPLASIA

ETV4 promotes proliferation and invasion of lung adenocarcinoma by transcriptionally upregulating MSI2

(2019) Tingting Cheng et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Contemporary Debates in Adult Papillary Thyroid Cancer Management

(2019) Donald S A McLeod et al.   ENDOCRINE REVIEWS

ETV4 overexpression promotes progression of non–small cell lung cancer by upregulating PXN and MMP1 transcriptionally

(2019) Yan Wang et al.   MOLECULAR CARCINOGENESIS

CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF‐MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement

(2019) Matteo Claudio Da Vià et al.   ONCOLOGIST

Therapeutic breakthroughs for metastatic thyroid cancer

(2019) Vera Tiedje et al.   Nature Reviews Endocrinology

Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells

(2018) Ekapot Singsuksawat et al.   Cancer Cell International

BAP1 links metabolic regulation of ferroptosis to tumour suppression

(2018) Yilei Zhang et al.   NATURE CELL BIOLOGY

Ferroptosis and Its Role in Diverse Brain Diseases

(2018) Abigail Weiland et al.   MOLECULAR NEUROBIOLOGY

RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer

(2018) Xinbing Sui et al.   Frontiers in Pharmacology

Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer

(2016) Jong-Lyel Roh et al.   CANCER LETTERS

Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis

(2016) Xiaofang Sun et al.   HEPATOLOGY

Ferroptosis as a p53-mediated activity during tumour suppression

(2015) Le Jiang et al.   NATURE

Sorafenib and Thyroid Cancer

(2013) Poupak Fallahi et al.   BIODRUGS

ETV1, 4 and 5: An oncogenic subfamily of ETS transcription factors

(2012) Sangphil Oh et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER